ROR1 and B-cell chronic lymphocytic leukemia: Liu et al. showed that ROR1 creates a loop with heat shock protein 90 (HSP90) leading to a high stabilization of ROR1 and lower the efficacy of Ibrutinib against CLL, however a ROR1 depletion by targeting HSP90 significantly increased Ibrutinib activity against CLL [139].